SCHEMBL7217283

SCHEMBL7217283

O=C(Nc1ccc(CC(O)C(=O)O)cc1)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
TP53 P04637 2/20 0.55
MAPT P10636 2/20 0.55
KDM1A O60341 3/20 0.54
MAOA P21397 2/20 0.54
MAOB P27338 2/20 0.54
MGLL Q99685 1/20 0.53
RCOR1 Q9UKL0 2/20 0.53
ROCK2 O75116 1/20 0.53
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
ALDH1A1 P00352 1/20 0.51
TSHR P16473 1/20 0.51
ATM Q13315 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CTRB1 P17538 2/20 0.50
ENPP2 Q13822 2/20 0.49
PTGDR2 Q9Y5Y4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7217491 0.89 POLB (0.57) POLBTP53MAPTKDM1AMAOA
SCHEMBL6051669 0.85 SLC7A5 (0.59) POLBTP53MAPTKDM1AMAOA
SCHEMBL6051665 0.85 SLC7A5 (0.59) POLBTP53MAPTKDM1AMAOA
SCHEMBL7357956 0.84 ITGB3 (0.61) KDM1AMAOAMAOBRCOR1
SCHEMBL22402969 0.84 SMN1; SMN2 (0.59) POLBTP53MAPTKDM1AMAOA
SCHEMBL21552129 0.84 SMN1; SMN2 (0.59) POLBTP53MAPTKDM1AMAOA
SCHEMBL7966954 0.82 POLB (0.58) POLBTP53MAPTKDM1AMAOA
SCHEMBL7966946 0.82 POLB (0.58) POLBTP53MAPTKDM1AMAOA
SCHEMBL10598558 0.82 POLB (0.69) POLBTP53MAPTKDM1AMAOA
Benzyl Phenylcarbamate SCHEMBL1222943 0.82 POLB (0.78) POLBTP53MAPTKDM1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531604-B2 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-03-11 US disclosed
US-20020128308-A1 Benzothiepine derivatives, their production and use YASUMA TSUNEO (JP) 2002-09-12 US disclosed
US-6355672-B1 BONE DISORDERS; CENTRAL NERVOUS SYSTEM DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-03-12 US disclosed
EP-1103552-A1 BENZOTHIEPIN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128308-A1 Benzothiepine derivatives, their production and use APP, BMP1, BACE1 POLB 3851/4885TP53 2752/4885MAPT 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.